“…[1][2][3][4][5][6][7][8][9][10][11] However, among patients with known cardiac disease, various studies have found a lower rate for adverse events among patients with increasing BMI, such as patients with heart failure, 16,17,21 patients undergoing percutaneous intervention, 15,18,19 patients with hypertension, 29 and peripheral arterial disease. 24 However, how weight impacts prognosis among patients without known CAD and a normal SPECT MPI is not well documented. In this study, we found that the obesity paradox extends to patients in whom functionally significant CAD has been excluded by cardiac testing, as determined by stress-rest myocardial perfusion imaging.…”